Company: RNAC
Filing Date: 2025-06-16
Form Type: 8-K
Source: 0001453687-25-000093
Chunk: 1

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-06-16
Form: 8-K
Item: Item 5.07
Chunk 1
---
 Votes FOR      Votes AGAINST      Votes ABSTAINED      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────────
  21,830,780              5,946               32,078      —                 

Based on the votes set forth above, the stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  CARTESIAN THERAPEUTICS, INC.                                             
  By:                               /s/ Carsten Brunn, Ph. D.              
                                    Carsten Brunn, Ph. D.                  
                                    President and Chief Executive Officer